Seqster Licenses SRP to La Jolla Institute of Immunology for Asthma Study
By Bio-IT World Staff
October 29, 2019 | Seqster has signed a 3-year licensing deal and partnership with La Jolla Institute of Immunology (LJI) to support the execution of a $6.9 million Asthma study funded by the National Institutes of Health/National Heart, Lung and Blood Institute (NIH NHLBI) that establishes one of only 10 PrecISE Network Clinical Centers nationwide. The new collaboration provides LJI with the Seqster Research Portal (SRP) technology that connects patients, clinicians and researchers to develop personalized treatments and find a cure for asthma by looking at longitudinal data for a 3-year period starting with 5000 participants.
The PrecISE network (Precision Interventions for Severe and/or Exacerbation-Prone Asthma), aims to identify more effective treatments for severe asthma. PrecISE is one of the most ambitious and innovative asthma trials to date that will support a personalized medicine approach to identifying therapies that are tailored to an individual’s disease.
“We needed a scalable and robust platform that supports rapid person-centric data aggregation as well as real-time collection of longitudinal health records data to build this important and ambitious research cohort,” says Stephen Wilson, Ph.D., Executive Vice President and Chief Operating Officer of LJI in a press release. “The Seqster Research Portal is the only platform that will allow our PrecISE study participants to instantly collect and share medical records, genomic and device data with our researchers from anywhere in the country in a secure and transparent way while maintaining data ownership.”
“A commitment of this magnitude from such a prestigious research institute as LJI is further validation that Seqster’s person-centric approach to health data interoperability brings together patients, clinicians and researchers to accelerate discoveries, and we’re thrilled we can help support it,” says Ardy Arianpour, CEO and Co-Founder of Seqster in the same release. “It is exciting that our SRP platform is providing the technology backbone for such an innovative clinical study infrastructure that will yield important efficacy and safety data on novel asthma interventions.”
US-based healthcare data sources through person-centric interoperability. Seqster helps healthcare providers and payers onboard their members in an efficient and accurate way by seamlessly integrating into any payer, provider, or clinical research enterprise. The platform currently connects users to more than 3,000 healthcare providers and over 100,000 hospitals and clinics nationwide. Seqster is privately held and headquartered in San Diego.